Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
EvoDevo is Scopus-indexed (Q1, CiteScore 6.3), DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 2041-9139Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Ecology, Evolution, Behavior and Systematics | 82 / 736 | 88th | Q1 |
| Developmental Biology | 22 / 78 | 72nd | Q2 |
| Genetics | 101 / 357 | 71st | Q2 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–2025, best quartile Q1, CiteScore 6.3.
EvoDevo is Q1 in Ecology, Evolution, Behavior and Systematics (rank 82 of 736), Q2 in Developmental Biology (rank 22 of 78) and Q2 in Genetics (rank 101 of 357), by CiteScore 2025.
EvoDevo is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 6.3, quartile Q1, 88th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.160, quartile Q1, with an H-index of 48.
The publisher lists an article processing charge of about US$2,690 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
EvoDevo is published by BioMed Central Ltd. Its ISSN is 2041-9139.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
EvoDevo has an h-index of 62 and a 2-year mean of 4.65 citations per paper (OpenAlex). Its Scopus CiteScore is 6.3, quartile Q1. On 2-year citations it ranks #47 of 711 Scopus journals in Ecology, Evolution, Behavior and Systematics.
EvoDevo published 17 papers in 2025; its busiest recent year was 2019 with 33. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 81 research articles (2021–2025), authors are most often from United States (36.1%), Japan (10%) and Germany (8.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.